• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Long-Term Outcomes of Endoscopic Resection versus Open Surgery for Locally Advanced Sinonasal Malignancies in Combination with Radiotherapy.内镜切除术与开放手术治疗局部晚期鼻窦恶性肿瘤联合放疗的长期疗效
J Neurol Surg B Skull Base. 2022 Dec 30;85(1):28-37. doi: 10.1055/a-1980-8567. eCollection 2024 Feb.
2
Intensity modulated radiation therapy (IMRT) for sinonasal tumors: a single center long-term clinical analysis.鼻窦肿瘤的调强放射治疗(IMRT):单中心长期临床分析
Radiat Oncol. 2016 Feb 4;11:17. doi: 10.1186/s13014-016-0595-9.
3
Long-term oncological outcomes for endoscopic endonasal versus open surgical approaches for anatomically matched, locally advanced stage T4 sinonasal malignancies with skull base involvement.内镜经鼻与开放性手术治疗局部晚期 T4 鼻窦恶性肿瘤伴颅底侵犯的解剖匹配患者的长期肿瘤学结果。
J Neurosurg. 2023 Sep 22;140(3):688-695. doi: 10.3171/2023.7.JNS23786. Print 2024 Mar 1.
4
Effects of gross tumor volume and radiation dose on survival and locoregional recurrence in early-stage extranodal NK/T-cell lymphoma treated with intensity-modulated radiation therapy.调强放疗治疗早期结外 NK/T 细胞淋巴瘤的肿瘤总体积和剂量对生存和局部区域复发的影响。
J Cancer Res Clin Oncol. 2023 Jul;149(8):5219-5230. doi: 10.1007/s00432-022-04472-6. Epub 2022 Nov 14.
5
Preoperative Intensified Chemoradiation with Intensity-Modulated Radiotherapy and Simultaneous Integrated Boost Combined with Capecitabine in Locally Advanced Rectal Cancer: Long-Term Outcomes of a Real-Life Multicenter Study.术前强化放化疗联合调强放疗、同步整合加量及卡培他滨治疗局部晚期直肠癌:一项真实世界多中心研究的长期结果
Cancers (Basel). 2023 Dec 4;15(23):5702. doi: 10.3390/cancers15235702.
6
Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy.与三维适形放疗相比,调强放疗可能改善局部晚期非小细胞肺癌的局部区域肿瘤控制。
Oncologist. 2016 Dec;21(12):1530-1537. doi: 10.1634/theoncologist.2016-0155. Epub 2016 Sep 14.
7
Endoscopic surgery compared with intensity-modulated radiotherapy in resectable locally recurrent nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial.内镜手术与调强放疗比较,用于可切除局部复发性鼻咽癌:一项多中心、开放标签、随机、对照、3 期临床试验。
Lancet Oncol. 2021 Mar;22(3):381-390. doi: 10.1016/S1470-2045(20)30673-2. Epub 2021 Feb 15.
8
Concurrent chemoradiotherapy versus radiotherapy alone for patients with locally advanced esophageal squamous cell carcinoma in the era of intensity modulated radiotherapy: a propensity score-matched analysis.调强放疗时代局部晚期食管鳞癌同期放化疗与单纯放疗的比较:倾向评分匹配分析。
Thorac Cancer. 2021 Jun;12(12):1831-1840. doi: 10.1111/1759-7714.13971. Epub 2021 May 5.
9
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.接受调强质子治疗与调强放射治疗的非转移性口咽癌患者的毒性特征和生存结果。
JAMA Netw Open. 2022 Nov 1;5(11):e2241538. doi: 10.1001/jamanetworkopen.2022.41538.
10
Comparison of endoscopic and open resection of sinonasal squamous cell carcinoma: a propensity score-matched analysis of 652 patients.内镜与开放手术切除鼻窦鳞状细胞癌的比较:652 例患者的倾向评分匹配分析。
Int Forum Allergy Rhinol. 2018 Mar;8(3):421-434. doi: 10.1002/alr.22040. Epub 2017 Dec 6.

本文引用的文献

1
The role of endoscopic resection for selected patients with sinonasal squamous cell carcinoma.内镜切除术在选择的鼻窦鳞状细胞癌患者中的作用。
Auris Nasus Larynx. 2021 Feb;48(1):131-137. doi: 10.1016/j.anl.2020.06.014. Epub 2020 Jul 25.
2
Outcomes and toxicities of definitive radiotherapy and reirradiation using 3-dimensional conformal or intensity-modulated (pencil beam) proton therapy for patients with nasal cavity and paranasal sinus malignancies.采用三维适形或调强(铅笔束)质子治疗技术对鼻腔和副鼻窦恶性肿瘤患者进行根治性放疗和再放疗的结果和毒性。
Cancer. 2020 Jan 1;126(9):1905-1916. doi: 10.1002/cncr.32776. Epub 2020 Feb 25.
3
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
4
Endoscopic resection of sinonasal malignancies.鼻窦恶性肿瘤的内镜切除术
Head Neck. 2020 Apr;42(4):645-652. doi: 10.1002/hed.26047. Epub 2019 Dec 24.
5
The value of preoperative radiotherapy in the treatment of locally advanced nasal cavity and paranasal sinus squamous cell carcinoma: A single institutional experience.术前放疗在局部晚期鼻腔及鼻窦鳞状细胞癌治疗中的价值:单机构经验
Oral Oncol. 2020 Feb;101:104512. doi: 10.1016/j.oraloncology.2019.104512. Epub 2019 Dec 21.
6
Margins in Sinonasal Squamous Cell Carcinoma: Predictors, Outcomes, and the Endoscopic Approach.鼻窦鳞状细胞癌的边缘:预测因素、结果和内镜方法。
Laryngoscope. 2020 Jun;130(6):E388-E396. doi: 10.1002/lary.28315. Epub 2019 Nov 22.
7
Endoscopic Versus Open Resection of Non-Squamous Cell Carcinoma Sinonasal Malignancies.内镜与开放手术切除非鳞状细胞鼻窦恶性肿瘤的比较。
Laryngoscope. 2020 Aug;130(8):1872-1876. doi: 10.1002/lary.28270. Epub 2019 Sep 12.
8
Timing of surgery and adjuvant radiation therapy for sinonasal malignancies: Effect of surgical approach.鼻-鼻窦恶性肿瘤手术和辅助放疗的时机:手术入路的影响。
Head Neck. 2019 Oct;41(10):3551-3563. doi: 10.1002/hed.25873. Epub 2019 Jul 11.
9
Sinonasal malignancies: Endoscopic treatment outcomes.鼻窦恶性肿瘤:内镜治疗结果。
Laryngoscope Investig Otolaryngol. 2019 Feb 6;4(2):259-263. doi: 10.1002/lio2.249. eCollection 2019 Apr.
10
Long-term Outcome for Open and Endoscopically Resected Sinonasal Tumors.经内镜与开放性鼻窦肿瘤切除术的长期疗效。
Otolaryngol Head Neck Surg. 2019 May;160(5):862-869. doi: 10.1177/0194599818815881. Epub 2018 Dec 4.

内镜切除术与开放手术治疗局部晚期鼻窦恶性肿瘤联合放疗的长期疗效

Long-Term Outcomes of Endoscopic Resection versus Open Surgery for Locally Advanced Sinonasal Malignancies in Combination with Radiotherapy.

作者信息

Liu Qian, Huang Xiaodong, Chen Xuesong, Zhang Jianghu, Wang Jingbo, Qu Yuan, Wang Kai, Wu Runye, Zhang Ye, Xiao Jianping, Yi Junlin, Luo Jingwei

机构信息

Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.

出版信息

J Neurol Surg B Skull Base. 2022 Dec 30;85(1):28-37. doi: 10.1055/a-1980-8567. eCollection 2024 Feb.

DOI:10.1055/a-1980-8567
PMID:38274487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10807958/
Abstract

Our objective was to compare the long-term outcomes of endoscopic resection versus open surgery in combination with radiotherapy for locally advanced sinonasal malignancies (SNMs).  Data for continuous patients with sinonasal squamous cell carcinoma and adenocarcinoma who received surgery (endoscopic or open surgery) combined with radiotherapy in our center between January 1999 and December 2016 were retrospectively reviewed. A 1:1 matching with propensity scores was performed. Overall survival (OS), progression-free survival (PFS), and local recurrence rate (LRR) were evaluated.  We identified 267 eligible patients, 90 of whom were included after matching: 45 patients in the endoscopy group and 45 in the open group. The median follow-up time was 87 months. In the endoscopic group, 84.4% of patients received intensity-modulated radiotherapy (IMRT), with a mean gross tumor volume (GTV) dose of 68.28 Gy; in the open surgery group, 64.4% of patients received IMRT, with a mean GTV dose of 64 Gy. The 5-year OS, PFS, and LRR were 69.9, 58.6, and 24.5% in the endoscopic group and 64.6, 54.4, and 31.8% in the open surgery group, respectively. Multivariable regression analysis revealed that the surgical approach was not associated with lower OS, PFS, or LRR. The overall postoperative complications were 13% in the endoscopic group, while 21.7% in the open group.  For patients with locally advanced SNMs, minimally invasive endoscopic resection, in combination with a higher radiation dose and new radiation techniques such as IMRT, yields survival outcomes similar to those of open surgery in combination with radiotherapy.

摘要

我们的目的是比较内镜切除术与开放手术联合放疗治疗局部晚期鼻窦恶性肿瘤(SNM)的长期疗效。回顾性分析了1999年1月至2016年12月期间在我们中心接受手术(内镜或开放手术)联合放疗的连续性鼻窦鳞状细胞癌和腺癌患者的数据。采用倾向评分进行1:1匹配。评估总生存期(OS)、无进展生存期(PFS)和局部复发率(LRR)。我们确定了267例符合条件的患者,其中90例在匹配后纳入:内镜组45例,开放组45例。中位随访时间为87个月。在内镜组中,84.4%的患者接受调强放疗(IMRT),平均肿瘤总体积(GTV)剂量为68.28 Gy;在开放手术组中,64.4%的患者接受IMRT,平均GTV剂量为64 Gy。内镜组的5年OS、PFS和LRR分别为69.9%、58.6%和24.5%,开放手术组分别为64.6%、54.4%和31.8%。多变量回归分析显示,手术方式与较低的OS、PFS或LRR无关。内镜组术后总体并发症发生率为13%,而开放组为21.7%。对于局部晚期SNM患者,微创内镜切除术联合更高的放疗剂量和IMRT等新放疗技术,其生存结果与开放手术联合放疗相似。